SAN FRANCISCO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Scality, a global leader in cyber-resilient storage software for the AI era, today announced the launch of its Pay-as-you-Go licensing model for Scality Cloud & Service Providers (SCSP). Specifically optimized for Veeam cloud service providers, this program features Scality ARTESCA as a 100% software storage backup target […]
San Antonio, TX, Jan. 29, 2025 (GLOBE NEWSWIRE) — Stirista, a leader in data-driven marketing innovation, has announced the acquisitions of Magnetik and Andrews Wharton, companies known for their expertise in data, creative and marketing strategy and execution. These strategic additions mark a pivotal moment in Stirista's continued growth, enhancing its ability to simplify the
Chicago, IL, Jan. 29, 2025 (GLOBE NEWSWIRE) — Belle Curve Stories is thrilled to spotlight Carrie May, an inspiring woman redefining what it means to live a vibrant, sober life. As the founder of the non-profit organization Chicago AF, Carrie is a trailblazer in the sober living movement, creating community and connection for those embracing
(NASDAQ:CRVO), BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that topline results from the Phase 2b RewinD-LB study will be presented at the 8th International Lewy Body Dementia Conference (ILBDC), being held in Amsterdam, on January 31, 2025.
(TSX-V:PHA), MONTREAL, Jan. 29, 2025 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health“), a leading Canadian health tech company, announces that its wholly owned subsidiary Canadian Health Care Agency Ltd (CHCA) was retained as service provider to provide travel nurse contingent labour services to the Nova Scotia Health
(NASDAQ:CMPX), BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will present at the Guggenheim Securities SMID Cap Biotech Conference taking place in New York City, NY February 5-6, 2025. Presentation Details Date:
(NASDAQ:CHEF), RIDGEFIELD, Conn., Jan. 29, 2025 (GLOBE NEWSWIRE) — The Chefs' Warehouse, Inc. (NASDAQ: CHEF) today announced that the Company intends to release its financial results for the fourth quarter and fiscal year ended December 27, 2024 before the opening of the stock market on Wednesday, February 12, 2025 and host a conference call at
(TSX:ILLM),(OTC US:ILLMF),(Other OTC:ILLMF), TORONTO and NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX: ILLM) (OTCQB: ILLMF) (“illumin” or “Company”), a leader in digital marketing technology, is excited to unveil its latest in-platform integration with Adsquare's Measurement solution, delivering store visit data directly to the illumin platform to enable advanced footfall attribution.
(NASDAQ:CABA), PHILADELPHIA, Jan. 29, 2025 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in a fireside chat at Guggenheim's SMID Cap Biotech Conference on Wednesday, February
(NYSE:NVRI), PHILADELPHIA, Jan. 29, 2025 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI) today announced that it will issue its fourth quarter and full year 2024 earnings results on Thursday, February 20, 2025, prior to NYSE market open. The Company will also host its quarterly conference call and webcast that morning beginning at 9:00 a.m. ET.